{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:19:30Z","timestamp":1784546370368,"version":"3.55.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Myasthenia gravis (MG) is an autoimmune disease characterized by chronic muscle fatigue and weakness caused by autoantibodies and complement-mediated damage at neuromuscular junctions. Histone deacetylases (HDACs) are crucial epigenetic regulators of proinflammatory gene expression; however, it is unclear whether HDACs modulate chronic inflammation or autoantibody production associated with MG pathogenesis. We examined expression profiles and serum levels of key inflammatory cytokines (IL-6 and IL-21) and acetylcholine receptor (AChR)-specific autoantibodies following pharmacological inhibition of key HDAC isoforms in a mouse model of MG. We found that HDAC inhibition significantly reduced the production of IL-6, but not IL-21, in AChR-stimulated PBMCs and splenocytes (<jats:italic>n<\/jats:italic> = 5 per group). Trichostatin (pan-HDAC inhibitor) treatment of MG-PBMCs (<jats:italic>n<\/jats:italic> = 2) also exhibited reduced production of induced IL-6. Although HDAC1 inhibition lowered IL-6 levels the most, HDAC2 inhibition depleted intracellular IL-6 and markedly reduced serum anti-AChR IgG2b in EAMG mice. The transcriptomic profiling and pathway mapping also revealed that autoimmunity-linked, major cell signaling pathways were differentially altered by HDAC1\/2 inhibition. HDAC inhibition-mediated reduction in IL-6 and autoantibody levels also correlated with milder disease and preservation of muscle AChR in the treated mice. Overall, our findings revealed isoform-specific functional variance of HDACs in reducing inflammation and identified HDAC-regulated many genes underlying specific inflammatory and autoantibody pathways in EAMG. Thus, the study provides a rationale for further research to evaluate the HDACs or their gene targets as a potential adjunct treatment for MG.<\/jats:p>","DOI":"10.3389\/fneur.2021.804113","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T09:49:00Z","timestamp":1644486540000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Histone Deacetylase Isoforms Differentially Modulate Inflammatory and Autoantibody Responses in a Mouse Model of Myasthenia Gravis"],"prefix":"10.3389","volume":"12","author":[{"given":"Afrin","family":"Bahauddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Ivannikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Jamaluddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naazneen","family":"Ibtehaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsey","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruksana","family":"Huda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/nyas.13522","article-title":"Myasthenia gravis: the role of complement at the neuromuscular junction","volume":"1412","author":"Howard","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/s-2004-829585","article-title":"Pathophysiology of myasthenia gravis","volume":"24","author":"Hughes","year":"2004","journal-title":"Semin Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jaut.2011.05.006","article-title":"Complement and cytokine based therapeutic strategies in myasthenia gravis","volume":"37","author":"T\u00fcz\u00fcn","year":"2011","journal-title":"J Autoimmun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-014-0179-6","article-title":"IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis","volume":"3","author":"Maurer","year":"2015","journal-title":"Acta Neuropathol Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.4049\/jimmunol.1500725","article-title":"Augmentation of circulating follicular helper T Cells and their impact on autoreactive B cells in myasthenia gravis","volume":"197","author":"Zhang","year":"2016","journal-title":"J Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"Il-6 in inflammation, Immunity, And disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: Regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur J Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1749-6632.1993.tb22873.x","article-title":"High IL-6 gene expression and production by cultured human thymic epithelial cells from patients with myasthenia gravis","volume":"681","author":"Cohen-Kaminsky","year":"1993","journal-title":"Ann N Y Acad Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","article-title":"Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production","volume":"169","author":"Deng","year":"2002","journal-title":"J Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaut.2010.12.001","article-title":"Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis","volume":"36","year":"2011","journal-title":"J Autoimmun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.nmd.2017.03.007","article-title":"Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab","volume":"27","author":"Jonsson","year":"2017","journal-title":"Neuromuscul Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1084\/jem.20081571","article-title":"The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4 + T cells","volume":"206","author":"Dienz","year":"2009","journal-title":"J Exp Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12026-020-09164-2","article-title":"IL-21 enhances STAT3\/Blimp-1 signaling pathway in B cells and contributes to plasma cell differentiation in newly diagnosed patients with myasthenia gravis","volume":"69","author":"Xu","year":"2021","journal-title":"Immunol Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis-autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123546","article-title":"Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK","volume":"10","author":"Yilmaz","year":"2015","journal-title":"PLoS ONE."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6142","DOI":"10.1074\/jbc.M113.517599","article-title":"Histone deacetylase inhibitors modulate interleukin 6-dependent CD4 + T cell polarization in vitro and in vivo","volume":"289","author":"Glauben","year":"2014","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10565-019-09459-7","article-title":"HDAC2-mediated upregulation of IL-6 triggers the migration of osteosarcoma cells","volume":"35","author":"Li","year":"2019","journal-title":"Cell Biol Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1101\/gad.962502","article-title":"Specific targeting and constitutive association of histone deacetylase complexes during transcriptional repression","volume":"16","author":"Li","year":"2002","journal-title":"Genes Dev."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/srep24318","article-title":"Histone H4 lysine 20 acetylation is associated with gene repression in human cells","volume":"6","author":"Kaimori","year":"2016","journal-title":"Sci Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jmb.2004.02.006","article-title":"Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis","volume":"338","author":"Gregoretti I","year":"2004","journal-title":"J Mol Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and deacetylation of non-histone proteins","volume":"363","author":"Glozak","year":"2005","journal-title":"Gene."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00092","article-title":"Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi","volume":"8","author":"Suraweera","year":"2018","journal-title":"Front Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2119\/molmed.2011.00030","article-title":"Inhibition in rheumatoid arthritis and juvenile idiopathic arthritis","volume":"17","author":"Vojinovic","year":"2011","journal-title":"Mol Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.4049\/jimmunol.176.8.5015","article-title":"Histone hyperacetylation is associated with amelioration of experimental colitis in mice","volume":"176","author":"Glauben","year":"2006","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35602-1","article-title":"CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus","volume":"8","author":"Choi","year":"2018","journal-title":"Sci Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jneuroim.2005.02.022","article-title":"Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis","volume":"164","author":"Camelo","year":"2005","journal-title":"J Neuroimmunol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201800039","article-title":"Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model","volume":"1","author":"Sun","year":"2018","journal-title":"Life Sci Alliance."},{"key":"B30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2217\/epi.14.36","article-title":"Histone deacetylase inhibitors: a potential epigenetic treatment for Duchenne muscular dystrophy","volume":"6","author":"Consalvi","year":"2014","journal-title":"Epigenomics."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1523s95","article-title":"Experimental autoimmune myasthenia gravis in the mouse","volume":"15","author":"Wu","year":"2011","journal-title":"Curr Protoc Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clim.2017.01.005","article-title":"High-dose BAFF receptor specific mAb-siRNA conjugate generates fas-expressing B cells in lymph nodes and high-affinity serum autoantibody in a myasthenia mouse model","volume":"176","author":"Ibtehaj","year":"2017","journal-title":"Clin Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jneuroim.2015.03.004","article-title":"IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB\/c mice","volume":"281","author":"Huda","year":"2015","journal-title":"J Neuroimmunol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/genes11050556","article-title":"Histone deacetylases (HDACs): evolution, specificity, role in transcriptional complexes, and pharmacological actionability","volume":"11","author":"Milazzo","year":"2020","journal-title":"Genes."},{"key":"B35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fimmu.2020.00240","article-title":"New approaches to targeting b cells for myasthenia gravis therapy","volume":"11","author":"Huda","year":"2020","journal-title":"Front Immunol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24061047","article-title":"Role of natural products in modulating histone deacetylases in cancer","volume":"24","author":"Merarchi","year":"2019","journal-title":"Molecules."},{"key":"B37","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/ard.2011.154211","article-title":"Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay","volume":"71","author":"Grabiec","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"8024","DOI":"10.1073\/pnas.86.20.8024","article-title":"Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation","volume":"86","author":"Raynal","year":"1989","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B40","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1749-6632.1987.tb51321.x","article-title":"Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis","volume":"505","author":"Howard FM","year":"1987","journal-title":"Ann N Y Acad Sci."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.804113\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T09:49:03Z","timestamp":1644486543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.804113\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":40,"alternative-id":["10.3389\/fneur.2021.804113"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.804113","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"article-number":"804113"}}